Aim: To compare the effectiveness and safety of fixed dose combination of vildagliptin 50mg
versus sitagliptin 50mg with metformin 500mg in Type 2 Diabetes Mellitus patients. Method …

Objective: The aim of the study to compare the efficacy of vildagliptin (50mg) and sitagliptin
(50mg) metformin (500mg) for type-2 diabetes mellitus. Methods: The treatment course …

Background: Inadequate control of blood glucose in patients leads to micro or
macrovascular complications. Metformin is an initial drug used to treat diabetes. In case of …

Objective: Addition of vildagliptin to ongoing insulin therapy may help in terms of overall
glycemic control as well as reduction in dose of insulin and weight. This study sought to …

Objective: To assess the safety and efficacy of Vildagliptin with metformin and Glimepiride
with metformin among Type 2 Diabetes Mellitus (T2DM) patients with inadequate glycemic …

Introduction: Diabetes is a complex, chronic illness requiring continuousmedical care with
multifactorial risk reduction strategies beyond glycemic control. Diabetes mellitus is resulting …

Background: Type 2 diabetes mellitus (DM) is mainly due to multifactorial of which insulin
resistance and deficiency in the incretion are two important pathophysiological factors …

Objectives: To compare the efficacy of add on therapy of Vildagliptin versus Pioglitazone
among Type 2 Diabetes Mellitus patients inadequately controlled on dual therapy of …

Background: Diabetes mellitus is a heterogeneous chronic metabolic disorder principally
characterized by persistent hyperglycemia resulting from defects in insulin action and/or …